Information system for monitoring environmental impacts of genetically modified organisms

Background, aim and scope  

European legislation stipulates that genetically modified organisms (GMO) have to be monitored to identify potential adverse environmental effects. A wealth of different types of monitoring data from various sources including existing environmental monitoring programmes is expected to accumulate. This requires an information system to efficiently structure, process and evaluate the monitoring data.     

Wassertechnische Strategien zur Reduzierung der Trinkwasserbelastung durch Arzneimittelwirkstoffe

Results The available research results concerning the application of innovative methods of wastewater and drinking water purification to eliminate pharmaceuticals are summarized in the present paper. An increase of the activated sludge (aerobic sludge) age to 8–10 days in treatment plants can improve the metabolization of less persistent pharmaceutical agents whereas expansion of the sojourn time beyond 10 days will not result in a remarked increase of degradation for most pharmaceutical substances. First results have shown that wastewater treatment plants with integrated membrane bioreactors (MBR) using micro- and ultrafiltration membranes do not provide significantly better results compared to the conventional wastewater treatment plants with respect to the removal of organic micropollutants (including pharmaceutical residues). The use of powdered carbon in biologically treated wastewater is able to reduce pharmaceutical residues up to 80?% in the run-off water. Pilot studies scrutinize the treatment of highly contaminated effluents via catalytic photooxidation. Regarding the suitability of the method to reduce the contamination of drinking and wastewater with pharmaceuticals yet only few data from laboratory scale testing are available. Activated carbon filtration is preferably used for drinking water treatment. Primarily against the background of disinfection, ozonation is widely used for drinking water treatment, but for wastewater treatment the method is still at the experimental stage and will hardly become of practical importance because of high costs. Sustainable wastewater separation is grounded on decentralized concepts by considering material cycles (recycling) at the place of origin. In the long term, separation measures can significantly contribute to declining drug concentrations in drinking water. Regarding the quarrying of drinking water by bank filtration water, river water or artificially enriched ground water, end-of-pipe techniques are vital. Most commonly, activated carbon or activated carbon combined with ozonization is applied and assures a high drinking water quality. Discussion The advantages and disadvantages of the different water treatment methods mainly concern the varying degrees of effectiveness with respect to the elimination of very persistent pharmaceutical agents, the generation of problematical metabolites and additional waste materials, hygienic problems, energy needs and the necessity to employ appropriate technical staff for operation. Although the biodegradation of very persistent drugs cannot be enhanced by an extension of the activated sludge age, this modification should be considered in sewage plants to reduce the contamination with less persistent medical agents. Compared with conventional wastewater treatment, membrane bioreactors provide the advantage of a better control of biological activities on the plant and a comparably small plant size but high investment and operation costs. Additionally, pharmaceuticals such as carbamazepin are only insufficiently removed from wastewater by membrane bioreactors. The regular use of powdered activated carbon in sewage treatment plants would also increase the costs of wastewater treatment and would additionally exclude the further use of sewage sludge in agriculture. Currently, in Germany the further use of sewage sludge is handled differently by the Federal States and discussed controversially. The implementation of ozonation as an additional treatment method in wastewater treatment plants is not realistic because of cost concerns. Additionally, the method produces analytically as yet not assessed metabolites with unknown (eco-)toxicological impacts. For this reason ozonation should currently not be applied unless the reaction products are removed subsequently by filtration through activated carbon. For industrial sewage photooxidation is in a state of testing but an application for municipal wastewater is, up to now, out of question. When river bank filtration is used for the supply of drinking water the use of activated carbon for purification should be essential. The lifetime of the filters is often defined by the filter capacities to eliminate radiocontrast media (e.?g., iopamidole, amidotrizoic acid). Many water supply companies already apply the ozonization prior to activated carbon filtration which supports the elimination of pharmaceuticals from the sewage. The unique developmental potential of the wastewater separation can be seen in the possibility to link up these methods with sustainable exploitation techniques and concepts (re-use of sanitized water, production of fertilizer, compost and biogas). Wastewater separation will not make ‘middle/end-of-pipe’ techniques dispensable but will make their handling more effective because concentrations of pharmaceutical agents are higher in separated effluents compared to those usually found in municipal wastewater, which in mixing sewage systems is even diluted by surface runoff. Conclusions Following today’s state of knowledge activated carbon filtration (eventually coupled with ozonization) is best suited to remove drug residues and other xenobiotics from raw water. Water works that do not apply the activated carbon filtration technique for cleanup of bank filtration water should consider an upgrade. The ozonization is primarily required for disinfection of the water. As no acute health hazard proceeds from drinking water contamination by pharmaceuticals at the present time, the upgrade of wastewater treatment plants by one of the aforementioned innovative methods is currently not required in view of drinking water quality. This offers the opportunity to develop sustainable approaches that already aim to reduce drug contaminations of wastewater and hence of ground-, surface- and drinking water. Recommendations and perspectives On a short- to mid-term perspective enriched sewage of hospitals, nursing homes and other medical facilities should be collected and treated separately. From a technical point of view the conditioning of separated hospital effluents (yellow- and greywater) via activated carbon or membrane filtration is possible but should be combined with disinfection. On a mid- and long-term scale sustainable sanitary concepts based on wastewater separation (black-, grey- and/or rainwater) associated with the recycling of mineral nutrients (nitrogen, phosphorous and potassium) should be realized for development, industry and trade areas, buildings with public lavatories, airports, motorway service areas, and large office and hotel buildings. Strategies focusing primarily on up-grading of municipal wastewater treatment plants are currently existing but the related technologies are largely in a test phase. This is why a particular technique should not be favored at the moment. The combination of various techniques (i.?e., ozonization combined with activated carbon filtration) is known to be very efficient for the removal of pharmaceutical residues from water, but the combination cannot be expected to become of importance in treatment of domestic wastewater because of high costs. Moreover, improvement of wastewater treatment technologies to remove pharmaceutical residues will not make the employment of end-of-pipe techniques in water works redundant and therefore will not lead to saving of expenses.     

Integrating disciplinary research into an interdisciplinary framework: A case study in sustainability research

The complexity of today’s research problems increasingly demands that scientists move beyond the confines of their own discipline. In this special issue, the basics of a transdisciplinary framework are established and problems analyzed in a specific discipline are successfully integrated in this transdisciplinary network. The intent has been to go beyond only statements about the importance of enabling early stage researchers to work across disciplinary boundaries, and to show that important discoveries are being made at the intersection of disciplines. Embedding various research projects in a more global framework can meet the demands of an interdisciplinary or transdisciplinary approach (especially for early stage researchers) and contribute significantly to sustainable research.     

Humanpharmakawirkstoffe in der Umwelt: Einträge, Vorkommen und der Versuch einer Bestandsaufnahme

Background

The presence of a large spectrum of pharmaceutical agents has been reported for aquatic environments (surface—and groundwater) and other aquatic media (influents and effluents of sewage treatment plants) in Germany and beyond, including their occurrence in drinking water. Considering the large number of pharmaceuticals produced for human use and released into the environment, various authors (Sattelberger 1999, Hanisch et al. 2004, Castiglioni et al. 2006, IWW 2006, Stockholm County Council 2006) tried to compile ‘priority lists’ focusing on those substances with environmental relevance. The following agents are included in all lists: ciprofloxacine, clarythromycine (antibiotics), carbamazepine (anti-epileptic agent), bezafibrate (lipid reducer), clofibric acid (lipid reducer metabolite), ethinylestradiol (sex hormone) and cylophosfamide (cytostatic agent). The agents erythromycine and sulfamethoxazole (antibiotics), ibuprofen, indometacine, propyphenazone (analgesics), atenolol (beta-blocker) and ifosfamide (cytostatic agent) can be found in three of four priority lists.

Results

Pharmaceuticals mainly enter the aquatic environment via effluent water, coming from wastewater treatment plants (including hospital and household sewerage), untreated discharges (e.g, secondary transfer of active agents into ground- and surface waters via sewage sludge application in agriculture and via landfill leachate) and leakages in the municipal sewer network.

Discussion

Potential activities towards a reduced release of pharmaceuticals into the environment should consider primarily the origin of the exposure to allow a separation of drug containing flows already at the source. Following the latter it would be possible to minimize the contamination of spring-, ground- and surface waters which serve as raw water resources for drinking water supply. However, considering the actual water pollution with pharmaceuticals and other substances, ‘end-of pipe’ techniques in the sewage and drinking water treatment are absolutely essential.

Conclusions

Sustainability criteria (e.g. protection of drinking water resources, habitats and biocoenoses, recycling and economizing use of resources) and economic aspects of modern sewage disposal concepts require a useful choice and combination of technical measures as components of centralized and decentralized sewage and drinking water treatment methods. It is though not realistic to cover and eliminate all pharmaceutical agents of environmental relevance equally effective even if a catalogue of potential technical treatment methods is elaborated thoroughly. Therefore, a concentration of efforts on selected drug agents, at least following initially some of the priority lists, is recommended.

Recommendations and Perspectives

The contamination of the water cycle with pharmaceuticals is nevertheless not exclusively to be solved via the application of technical methods. The BMBF (Federal Ministry for Education and Research) funded project start (Management Strategies for Pharmaceuticals in Drinking Water, www.start-project.de) therefore tries by implementation of a transdisciplinary approach to integrate technical-, behavioral-, and agent-orientated management strategies towards a more comprehensive and sustainable problem solution.     

Using land use/land cover trajectories to uncover ecosystem service patterns across the Alps

Regional Environmental Change - Managing multiple ecosystem services (ES) in agricultural landscapes is a challenging task, especially in regions with complex topographical and agro-ecological...     

Entwicklung eines Sedimentbiotests mit der ZwergdeckelschneckePotamopyrgus antipodarum (Gastropoda: Prosobranchia)

Currently, only few organismic biotest systems are available for the assessment of effects on reproduction, which consider an exposure toward whole sediments. A well-suited test organism is the parthenogenetic mudsnailPotamopyrgus antipodarum. This ovoviviparous prosobranch snail lives in the upper layers of freshwater and brackish sediments. The number of (unshelled) embryos turned out to be a very sensitive parameter for the indication of sediment components affecting reproduction. Additionally, this endpoint allows to signal possible estrogenic sediment compounds. With this 28-day bioassay, laboratory tests on the effects of various chemicals onP. antipodarum were performed, e.g. triphenyltin and bisphenol A, in relevant environmental concentration ranges. Furthermore, the suitability of our test system for the investigation of complex and multiple level ranged contaminations was examined by means of various natural sediments from the Neiße and Odra rivers.